 <h1>Triclabendazole Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to triclabendazole: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, triclabendazole may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking triclabendazole:</p><p>
<i>More common</i>
</p><ul>
<li>Dizziness or lightheadedness</li>
<li>feeling of constant movement of self or surroundings</li>
<li>sensation of spinning</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chest pain, discomfort, or tightness</li>
<li>cough</li>
<li>difficulty breathing</li>
<li>fever</li>
<li>nausea</li>
<li>spinal pain</li>
<li>upper right abdominal pain</li>
<li>vomiting</li>
<li>yellow skin or eyes</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of triclabendazole may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Decreased appetite</li>
<li>diarrhea</li>
<li>headache</li>
<li>increased sweating</li>
<li>skin rash</li>
<li>stomach pain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abnormal color of urine</li>
<li>back pain</li>
<li>constipation</li>
<li>difficulty in moving</li>
<li>itching</li>
<li>joint pain</li>
<li>lack or loss of strength</li>
<li>muscle pain or stiffness</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to triclabendazole: oral tablet</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (included upper abdominal pain, abdominal pain; up to 93%), nausea (up to 18%)</p>
<p><b>Common</b> (1% to 10%): Vomiting, diarrhea</p>
<p><b>Frequency not reported</b>: Constipation<sup>[Ref]</sup></p><p>Some side effects associated with this drug treatment in fascioliasis (e.g., abdominal pain) could be secondary to the infection; such effects may be more severe and/or may occur more often in patients with heavy worm burden.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hyperhidrosis (up to 25%), urticaria (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Pruritus<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (up to 18%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 14%)</p>
<p><b>Common</b> (1% to 10%): Vertigo<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Posttreatment elevations in bilirubin, AST, and ALT were reported in 6.8%, 4.5%, and 3% of patients with normal liver enzyme values at baseline, respectively.</p>
<p></p>
<p>Some side effects associated with this drug treatment in fascioliasis (e.g., biliary colic, jaundice) could be secondary to the infection; such effects may be more severe and/or may occur more often in patients with heavy worm burden.</p><p><b>Common</b> (1% to 10%): Elevated bilirubin, elevated AST, elevated ALT, jaundice (included jaundice, ocular icterus)</p>
<p><b>Frequency not reported</b>: Biliary colic, transient increases in liver enzymes, transient increases in total bilirubin</p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea, cough<sup>[Ref]</sup></p><h3>Other</h3><p>Posttreatment elevations in alkaline phosphatase were reported in 4.2% of patients with normal liver enzyme values at baseline.</p>
<p></p>
<p>Resistance to this drug has been reported outside the US.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Elevated alkaline phosphatase, asthenia, chest pain, pyrexia, chest discomfort</p>
<p><b>Postmarketing reports</b>: Drug resistance<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Musculoskeletal chest pain</p>
<p><b>Frequency not reported</b>: Arthralgia, back pain, spinal pain<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Chromaturia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Egaten (triclabendazole)." Novartis Pharmaceuticals, East Hanover, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about triclabendazole</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>1 Review</li>
<li>Drug class: anthelmintics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Egaten</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Fascioliasis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to triclabendazole: oral tablet</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (included upper abdominal pain, abdominal pain; up to 93%), nausea (up to 18%)</p><p><b>Common</b> (1% to 10%): Vomiting, diarrhea</p><p><b>Frequency not reported</b>: Constipation<sup>[Ref]</sup></p><p>Some side effects associated with this drug treatment in fascioliasis (e.g., abdominal pain) could be secondary to the infection; such effects may be more severe and/or may occur more often in patients with heavy worm burden.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hyperhidrosis (up to 25%), urticaria (up to 11%)</p><p><b>Common</b> (1% to 10%): Pruritus<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (up to 18%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 14%)</p><p><b>Common</b> (1% to 10%): Vertigo<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Posttreatment elevations in bilirubin, AST, and ALT were reported in 6.8%, 4.5%, and 3% of patients with normal liver enzyme values at baseline, respectively.</p><p></p><p>Some side effects associated with this drug treatment in fascioliasis (e.g., biliary colic, jaundice) could be secondary to the infection; such effects may be more severe and/or may occur more often in patients with heavy worm burden.</p><p><b>Common</b> (1% to 10%): Elevated bilirubin, elevated AST, elevated ALT, jaundice (included jaundice, ocular icterus)</p><p><b>Frequency not reported</b>: Biliary colic, transient increases in liver enzymes, transient increases in total bilirubin</p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea, cough<sup>[Ref]</sup></p><h3>Other</h3><p>Posttreatment elevations in alkaline phosphatase were reported in 4.2% of patients with normal liver enzyme values at baseline.</p><p></p><p>Resistance to this drug has been reported outside the US.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Elevated alkaline phosphatase, asthenia, chest pain, pyrexia, chest discomfort</p><p><b>Postmarketing reports</b>: Drug resistance<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Musculoskeletal chest pain</p><p><b>Frequency not reported</b>: Arthralgia, back pain, spinal pain<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Chromaturia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Egaten (triclabendazole)." Novartis Pharmaceuticals, East Hanover, NJ. </p><h2>More about triclabendazole</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>1 Review</li>
<li>Drug class: anthelmintics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Fascioliasis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>